322510 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
JLK, Inc. engages in the development of artificial intelligence-based stroke treatment solutions. It provides early diagnosis of diseases, assistance with reading, lesion detection, and prognosis prediction through medical imaging and clinical data analysis using artificial intelligence. The company was founded by Won-Tae Kim on February 18, 2014 and is headquartered in Cheongju-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
322510 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company